DJIA 17,689.86 -56.12 -0.32%
NASDAQ 5,128.28 -0.50 -0.01%
S&P 500 2,103.84 -4.79 -0.23%
market minute promo

Omeros (NASDAQ: OMER)

16.10 -0.06 (-0.37%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

OMER $16.10 -0.37%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $16.17
Previous Close $16.16
Daily Range $15.99 - $16.69
52-Week Range $11.18 - $27.64
Market Cap $609.1M
P/E Ratio -7.38
Dividend (Yield) $0.00 (0.0%)
Volume 196,366
Average Daily Volume 486,017
Current FY EPS -$1.36

Sector

Healthcare

Industry

Drug Makers

Omeros (OMER) Description

Omeros Corporation is a clinical-stage Biopharmaceutical Company engaged in discovering developing and commercializing products focused on inflammation and disorders of the central nervous system. Website: http://www.omeros.com/

News & Commentary

Why Omeros Corporation Shares Plunged Today

A public share offering caused Omeros Corporation shares to sink by 10%.

Omeros Corporation: Not Light On Simons' Secret Sauce

Omeros Announces FDA Grants Fast Track Designation to Complement Inhibitor OMS721 for aHUS

Strong On High Volume: Omeros (OMER)

Omeros (OMER) Weak On High Volume Today

3 Pharmaceutical Stocks to Sell Now

Omeros Corporation's OMS721 And Its Potential At TTP

Several Key Events Coming Up For Omeros

Omidria Receives Positive Opinion from European Medicines Agency's Committee for Medicinal Products

Omidria Receives Positive Opinion from European Medicines Agency's Committee for Medicinal Products for Human Use

Earnings Reaction History: Omeros Corporation, 25.0% Follow-Through Indicator, 23.2% Sensitive

Omeros Corporation's Omidria Has Hallmarks Of Success

See More OMER News...

OMER's Top Competitors

OMER $16.10 (-0.37%)
Current stock: OMER
AMGN $176.59 (2.85%)
Current stock: AMGN
GILD $117.86 (-0.03%)
Current stock: GILD
BIIB $318.78 (0.56%)
Current stock: BIIB